Table 3.
Susceptibility* of Campylobacter concisus to 30 antimicrobial agents.
| Antibiotic | Tanner et al. (1981) | Johnson et al. (1986) | Aabenhus et al. (2005b)# |
Vandenberg et al. (2006) | Bergey’s (Vandamme et al., 2005) | |
|---|---|---|---|---|---|---|
| Group 1 | Group 2 | |||||
| Amikacin | – | >64 | – | – | – | – |
| Ampicillin | – | – | 1.5 | 0.38 | 2.0 | – |
| Bacitracin | >128 | – | – | – | – | 128 |
| Cefazolin | – | >128 | – | – | – | – |
| Cefoperazone | – | >128 | – | – | – | – |
| Cefotaxime | – | 4.0 | – | – | – | – |
| Cefoxitin | – | >128 | – | – | – | – |
| Ceftazidime | – | 64 | – | – | – | – |
| Ceftriaxone | – | – | 2.0 | 0.5 | – | – |
| Chloramphenicol | 4.0 | 4.0 | – | – | – | 4.0 |
| Ciprofloxacin | – | ≤1.0 | 0.094 | 0.125 | 0.25 | – |
| Clindamycin | 2.0–4.0 | 1.0 | – | – | – | 24 |
| Colistin | 0.5–1.0 | – | – | – | – | 0.5–1.0 |
| Erythromycin | 4.0 | 2.0 | 3.0 | 3.0 | 4.0 | 4.0 |
| Gentamicin | 2.0–4.0 | >32 | – | – | 1.0 | 24 |
| Imipenem | – | ≤1.0 | – | – | – | – |
| Kanamycin | 1.0–2.0 | – | – | – | – | 12 |
| Mecillinam | – | – | 3.0 | 3.0 | – | – |
| Metronidazole | 0.5–2.0 | 1.0 | – | – | – | 0.5–2.0 |
| Minocycline | 2.0 | – | – | – | – | 2.0 |
| Moxalactam | – | 128 | – | – | – | – |
| Nalidixic acid | 64–128 | – | – | – | 32 | 64–128 |
| Neomycin | 16–32 | – | – | – | – | 16–32 |
| Penicillin | 0.5–4.0 | 8.0 | – | – | – | 0.5–4.0 |
| Piperacillin | – | 256 | – | – | – | – |
| Polymixin B | ≤0.25–1.0 | – | – | – | – | 0.25–1.0 |
| Rifampin | 16–64 | – | – | – | – | 16–64 |
| Streptomycin | 1.0–2.0 | – | – | – | – | 12 |
| Tetracycline | 1.0–2.0 | 1.0 | 0.5 | 0.75 | 0.5 | 12 |
| Vancomycin | >128 | – | – | – | – | 128 |
*MIC90 represents the MIC that completely inhibited visible growth of 90% of the strains. #C. concisus strains were split into two groups based on their protein profiles.